Arcellx, Inc. - Common Stock (ACLX)

CUSIP: 03940C100

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock
Shares outstanding
58,974,400
Total 13F shares
59,173,488
Share change
+1,799,193
Total reported value
$4,537,933,690
Put/Call ratio
100%
Price per share
$76.69
Number of holders
208
Value change
+$127,885,655
Number of buys
109
Number of sells
80

Quarterly Holders Quick Answers

What is CUSIP 03940C100?
CUSIP 03940C100 identifies ACLX - Arcellx, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of ACLX - Arcellx, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FMR LLC
13F
Company
11%
6,479,273
$541,084,111 30 Sep 2024
13F
GILEAD SCIENCES, INC.
3/4/5
10%+ Owner
class O/S missing
6,720,803
$371,444,668 28 Dec 2023
BlackRock, Inc.
13F
Company
7.2%
4,246,692
$354,641,248 30 Sep 2024
13F
Paradigm Biocapital Advisors LP
13F
Company
6.8%
4,000,000
$334,040,000 30 Sep 2024
13F
PERCEPTIVE ADVISORS LLC
13F
Company
6.6%
3,888,669
$324,742,748 30 Sep 2024
13F
NEA Management Company, LLC
13F
Company
6.4%
3,745,262
$312,766,830 30 Sep 2024
13F
NEA Partners 15, L.P.
3/4/5
10%+ Owner
class O/S missing
4,745,262
$262,260,666 20 Dec 2022
New Enterprise Associates 15, L.P.
3/4/5
10%+ Owner
class O/S missing
4,745,262
$262,260,666 20 Dec 2022
Novo Holdings A/S
3/4/5
10%+ Owner
class O/S missing
4,016,878
$222,004,412 08 Feb 2022
VANGUARD GROUP INC
13F
Company
4.2%
2,462,096
$205,609,637 30 Sep 2024
13F
SR ONE CAPITAL MANAGEMENT, LP
13F
Company
4%
2,346,630
$195,967,071 30 Sep 2024
13F
JANUS HENDERSON GROUP PLC
13F
Company
3.4%
2,011,950
$168,025,613 30 Sep 2024
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
3.2%
1,900,611
$158,721,000 30 Sep 2024
13F
RA CAPITAL MANAGEMENT, L.P.
13F
Company
3.1%
1,851,479
$154,617,011 30 Sep 2024
13F
STATE STREET CORP
13F
Company
2.6%
1,544,939
$129,017,856 30 Sep 2024
13F
Lewis T. "rusty" Williams
3/4/5
Director
class O/S missing
2,095,114
$115,792,551 08 Feb 2022
Cormorant Asset Management, LP
13F
Company
2.1%
1,250,000
$104,387,500 30 Sep 2024
13F
SR ONE CAPITAL MANAGEMENT, LLC
3/4/5
10%+ Owner
class O/S missing
1,658,780
$91,677,287 11 May 2023
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.7%
974,967
$81,433,886 30 Sep 2024
13F
T. Rowe Price Investment Management, Inc.
13F
Company
1.6%
944,638
$78,887,000 30 Sep 2024
13F
LORD, ABBETT & CO. LLC
13F
Company
1.5%
891,848
$74,478,000 30 Sep 2024
13F
MORGAN STANLEY
13F
Company
1.3%
757,152
$63,229,821 30 Sep 2024
13F
SUVRETTA CAPITAL MANAGEMENT, LLC
13F
Company
1.2%
689,950
$57,617,725 30 Sep 2024
13F
Vestal Point Capital, LP
13F
Company
1.1%
675,000
$56,369,250 30 Sep 2024
13F
DEUTSCHE BANK AG\
13F
Company
0.79%
465,690
$38,889,772 30 Sep 2024
13F
Affinity Asset Advisors, LLC
13F
Company
0.68%
400,000
$33,404,000 30 Sep 2024
13F
NORTHERN TRUST CORP
13F
Company
0.65%
384,108
$32,076,860 30 Sep 2024
13F
Samsara BioCapital, LLC
13F
Company
0.6%
353,641
$29,532,560 30 Sep 2024
13F
BAMCO INC /NY/
13F
Company
0.58%
342,832
$28,629,900 30 Sep 2024
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.56%
328,093
$27,399,046 30 Sep 2024
13F
Russell Investments Group, Ltd.
13F
Company
0.54%
320,670
$26,779,193 30 Sep 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.51%
299,259
$24,991,119 30 Sep 2024
13F
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
0.5%
292,009
$24,385,672 30 Sep 2024
13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
0.48%
282,855
$23,621,220 30 Sep 2024
13F
Integral Health Asset Management, LLC
13F
Company
0.47%
275,000
$22,965,250 30 Sep 2024
13F
JPMORGAN CHASE & CO
13F
Company
0.42%
250,123
$20,887,772 30 Sep 2024
13F
S.c.a. Candriam
13F
Individual
0.41%
240,363
$20,071,815 30 Sep 2024
13F
VICTORY CAPITAL MANAGEMENT INC
13F
Company
0.39%
227,419
$18,991,761 30 Sep 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.37%
220,352
$18,401,595 30 Sep 2024
13F
First Turn Management, LLC
13F
Company
0.36%
214,298
$17,896,026 30 Sep 2024
13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC
13F
Company
0.29%
169,262
$14,135,070 30 Sep 2024
13F
EAGLE ASSET MANAGEMENT INC
13F
Company
0.21%
122,329
$12,607,226 30 Sep 2024
13F
TD ASSET MANAGEMENT INC
13F
Company
0.25%
149,518
$12,374,110 30 Sep 2024
13F
VOYA INVESTMENT MANAGEMENT LLC
13F
Company
0.25%
146,648
$12,246,575 30 Sep 2024
13F
Nuveen Asset Management, LLC
13F
Company
0.2%
120,896
$10,096,025 30 Sep 2024
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.2%
119,075
$9,943,571 30 Sep 2024
13F
Bank of New York Mellon Corp
13F
Company
0.2%
117,059
$9,775,597 30 Sep 2024
13F
Woodline Partners LP
13F
Company
0.19%
110,989
$9,268,691 30 Sep 2024
13F
GREAT POINT PARTNERS LLC
13F
Company
0.17%
100,000
$8,351,000 30 Sep 2024
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.16%
95,868
$8,005,937 30 Sep 2024
13F

Institutional Holders of Arcellx, Inc. - Common Stock (ACLX) as of Q4 2024

As of 31 Dec 2024, Arcellx, Inc. - Common Stock (ACLX) was held by 208 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 59,173,488 shares. The largest 10 holders included FMR LLC, GILEAD SCIENCES, INC., Paradigm Biocapital Advisors LP, BlackRock, Inc., NEA Management Company, LLC, PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, RA CAPITAL MANAGEMENT, L.P., SR One Capital Management, LP, and PRICE T ROWE ASSOCIATES INC /MD/. This page lists 209 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders
185
Q4 2024 holders
208
Holder diff
23
Investor Q3 2024 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2024 Value $ Q4 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.